Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Etodolac for Bleaching-Induced Tooth Sensitivity
NCT02881619Phase 4Completed
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of etodolac in dentin hypersensitivity (DH). Started Nov 2014; status: completed.
02
Drugs
etodolac
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT02881619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02881619.